Lubna Chaudhary is an Oncology physician affiliated with Medical College of Wisconsin. OpenAlex indexes 72 publications with 612 citations (h-index 13); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9200 W Wisconsin Ave
Hematology And Oncology
Milwaukee, WI 532263522
Telephone
414-805-6800Provider last certified this registry record 1 Oct 2020.
Clinical trials
- Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors
Sponsor: Medical College of Wisconsin
- Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
Sponsor: Medical College of Wisconsin
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20257 payments
- Daiichi Sankyo Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
82.8%Aromatase Inhibitor62.5%Anastrozole85%Letrozole9%Exemestane6%Part D<11 patientsEstrogen Agonist/Antagonist17%Tamoxifen Citrate100%Part D≥36 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.5%Serotonin-3 Receptor Antagonist6.5%Ondansetron Hcl100%Part D≥24 patientsSensory organs
4.3%Corticosteroid4.3%Dexamethasone100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2022 per NIH RePORTER. The latest:
- Quantitative Analyses of HER2 Upregulation in Luminal Breast Cancer in Response to Neoadjuvant Endocrine Therapy
Medical College of Wisconsin
FY2022$81,220R03CA259594 - Quantitative Analyses of HER2 Upregulation in Luminal Breast Cancer in Response to Neoadjuvant Endocrine Therapy
Medical College of Wisconsin
FY2021$88,778R03CA259594
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiac MRI for differentiating chemotherapy-induced cardiotoxicity in sarcoma and breast cancer
Radiology and Oncology
2025 - The Influence of Socioeconomic Status on Stage at Diagnosis and Survival in Young Breast Cancer Patients
Clinical Breast Cancer
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Reza Shaker, MD
Medical College of Wisconsin
Michael Widlansky, MD
Medical College of Wisconsin
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”